Professor Emyr Lloyd-Evans is deputy director of the Medicines Discovery Institute at Cardiff University where he specialises in small-molecule therapy development for lysosomal storage disorders. He has an applied undergraduate masters degree in biochemistry (M.Biochem) from the University of Bath, graduating in 2002, during which time he spent ~15 months on a placement at the Weizmann Institute of Science, Israel. He obtained his PhD in 2006 (D.Phil) from the Glycobiology Institute, University of Oxford, where he specialised in Niemann–Pick disease. Following post-doctoral work studying lysosomal Ca2+ signalling in disease at the Department of Pharmacology (Oxford), he moved to Cardiff University in 2010 as an RCUK Fellow and March of Dimes Basil O’Connor starter scholar.